Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Development and study of a monoclonal antibody to the human HLA-class II invariant chain
The work I present in this thesis was initiated by a request for a monoclonal antibody (MoAb) to the peripheral blood cells of a patient with chronic lymphocytic leukemia (CLL). It was initially hoped that such an antibody, if directed against an idiotypic determinant on the malignant B-cell surface...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Biological Sciences
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| Summary: | The work I present in this thesis was initiated by a request for a monoclonal antibody (MoAb) to the peripheral blood cells of a patient with chronic lymphocytic leukemia (CLL). It was initially hoped that such an antibody, if directed against an idiotypic determinant on the malignant B-cell surface, may prove to be useful therapeutically by virtue of its specificity and limited reactivity. At the time at which the request was made there had already been favourable reports of the use of MoAb's for the management of B-cell derived malignancies |
|---|